Disputes still arise about the adverse effect of perioperative transfusion on survival of patients with malignant solid tumors. In order to find some answers to these controversies the author has studied 880 new patients with operable breast cancer, among whom 486 (55.2%) had received perioperative transfusion. In 86% of the patients the tumor size, when known, measured 3.0 cm (T2) or less. In general the ten-year actuarial survival of the 486 transfused patients has been 59.9% versus 66.7% for 394 nontransfused ones, X2 = 4.47; d.o.f. = 1, P <0.05.
In multivariate analysis it was noted that only positive nodes had affected the survival significantly (P = 10-9) and blood group had produced a trend (P = 0.08). However, when the period cohort was eliminated, the adverse effect of transfusion became evident in patients with blood group A in the 1968-69 and 1970-71 cohorts but not in those with blood group O.
It is concluded that the combined effect of transfusion and blood group, as a risk factor, is not as strong as positive nodes and large size of tumor. This study confirms that transfusion effect, at surgery, is a blood-group-related phenomenon.
References
1.
Burrows L., Tartter P.: Effect of blood transfusion on colonic malignancy recurrence rate. Lancet2:662-662, 1982.
2.
Foster RS Jr,Costanza MC, Foster JC, et al: Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer55:1195-1201, 1985.
3.
Tartter PI, Burrows L., Papatestas AE, et al: Perioperative blood transfusion has prognostic significance for breast cancer. Surgery97:225-229, 1985.
4.
Rosenberg SA , Seipp CA, White DE, et al: Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extrimities. J Clin Oncol3:698-709, 1985.
5.
Tartter PI, Burrows L., Kirschner P.: Perioperative blood transfusion adversely affects prognosis after resection of stage I (subset NO) non-oat cell lung cancer. J Thorac Cardiovasc Surg88:659-662, 1984.
6.
Blumberg N., Agarwal NM, Chung C.: Relationship between recurrence of cancer of colon and blood transfusion. Br Med J290:1038-1039, 1985.
7.
Blumberg N., Heal JM, Murphy P., et al: Association between transfusion of whole blood and recurrence of cancer. Br Med J293:530-535, 1986.
8.
Voogt PL, van de Velde CJH, Brand A., et al: Perioperative transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer59:836-843, 1987.
9.
Van Lawick Van Pabst WP, Langenhorst Blam, Mulder Pgh, et al: Effect of perioperative blood loss and perioperative blood transfusion on colorectal cancer survival. Eur J, Cancer Clin Oncoll24:741-747, 1988.
10.
Francis Dma , Judson RT: Blood transfusion and recurrence of cancer of the colon and rectum. Br J Surg74:26-30, 1987.
11.
Salsali M., Bufalino R., Morabito A.: Combined effect of transfusion and blood groups on survival of patients with breast cancer. A clinical study of 901 patients. Vasc Surg22:402-412, 1988.
12.
Crowe JP, Gordon NH, Fry DE, et al: Breast cancer survival and perioperative blood transfusion. Surgery106:836-841, 1989.
13.
Chesi R., Cazzola A., Baci G., et al: Effect of perioperative transfusion on survival in osteosarcoma treated by mutimodality therapy. Cancer64:1727-1737, 1989.
14.
Moores Dwo, Piantandosi S., McKneally MF: Effect of perioperative blood transfusion on outcome in patients with surgically treated lung cancer. Ann Thorac Surg48:346-351, 1989.
15.
Lieward F., Wirsching RP, Zulke C., et al: Influence of blood transfusion and tumor recurrence and survival rate in colorectal carcinoma. Eur J Cancer26:327-335, 1990.
16.
Marsh J., Donnan PT, Hamer-Hodges DW: Association between transfusion with plasma and the recurrence of colorectal carcinoma. Br J Surg77:623-626, 1990.
17.
Schricker KT , Hermanek P., Guggemoos-Holzmann I., et al: Decreased survival in colorectal cancer. Surprising results of a multivariate analysis. Beitr Infusionther26:307-312, 1990.
18.
Hyman NH, Foster RS, DeMeules JE, et al: Blood transfusion and survival after lung cancer resection. Am J Surg149:502-507, 1985 .
19.
Foster RS Jr, Foster JC, Costanza MC: Blood transfusion and survival after surgery for breast cancer. Arch Sur119:1136-1140,984.
20.
Frankish PD , McNee RK, Alley PG, et al: Relation between cancer of the colon and blood transfusion. Br Med J290:1827-1827, 1985.
21.
Francis D., Judson R.: Relation between recurrence of cancer of colon and blood transfusion. Br Med J291:544-544, 1985.
22.
Mayonda IT, Shaw DE, Folks et al: Renal cell Carcinoma: Blood transfusion and survival. Br Med J293:537-538, 1986.
23.
Pastorino U. , Valente M., Cataldo I., et al: Perioperative blood transfusion and prognosis of resected stage Ia lung cancer. Eur J Cancer Clin Oncol22:1375-1386, 1986.
24.
Keller SM, Grohen S., Martini N., et al: Blood transfusion and lung cancer recurrence. Cancer62:606-610, 1988.
25.
Kieckbush ME , O'Fallon JR, Ahman DL, et al: Blood transfusion exposure does not influence survival in patients with carcinoma of breast. Transfusion29:500-504, 1989.
26.
Crowson MC, Hallissey MT, Kiff RS, et al: Blood transfusion in colorectal cancer. Br J Surg76:522-523, 1989.
27.
Kaùpschoer Ghm, Maruyama K., Sasako M., et al: The effect of blood transfusion on prognosis of patients with gastric cancer. World J Surg13:637-643, 1989.
28.
Jakobsen EB , Eikoff JR, Andersen J., et al: Perioperative blood transfusion and recurrence and death after reaction for cancer of the colon and rectum. Scand J Gastroentrol25:435-442, 1990.
29.
Bentzen SM, Balslev IB, Pederson M., et al: Blood transfusion and prognosis in Dukes' B and C colorectal cancer. Eur J Cancer26:457-463, 1990.
30.
Moriguchi S. , Mahara Y., Kazawa K., et al: Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer . Cancer66:2331-2335, 1990 .
31.
Cheslyn-Curtis S., Fielding PL, Hittinger R., et al: Large bowel cancer: The effect of perioperative blood transfusion on outcome. Ann R Coll Surg72:52-59, 1990.
32.
Salsali M., Bufalino R., Morabito A.: Breast cancer survival and transfusion: A clinical study of 900 patients. In press.
33.
Kaplan E., Meier P.: Nonparametric estimation from incomplete observation. J Am Stat Assoc53:457-481, 1958.
34.
Cox DR: Regression models and life-tables. J R Stat Soc34:178-202, 1972.
35.
Morabito A., Marbini E.: TABSUR: A program featured to aid statistical analysis in cancer research. Acts de la Jourée de travail: Analyse-des Données, INRIAechesnay1989, pp393-408.
36.
Marubini E. , Morabito A., Valsechi MG: Prognostic factors and risk groups: Some results given by using an algorithm suitable for censored survival data. Stat Med2:295-303, 1983.
37.
Singal DP, Joseph S., Szewczuk MR: Possible mechanism of the beneficial effect of pretransplant blood transfusions on renal allograft survival in man. Transplant Proc14:316-318, 1982.
Joysey VC, Roger JH, Evan DB, et al: Kidney graft survival and matching for HL-A and ABO antigens . Nature246:163-165, 1973.
40.
Opelz G., Trasaki PI: Effect of blood-group on relation between HLA match and outcome of cadaver kidney transplants. Lancet1: 220-222, 1977.
41.
Dintenfass L., Stewart JH, Milton GW, et al: Influence of ABO blood groups and fibrinogen on thrombus formation and aggregation of red cells in cardiovascular and malignant disease. Biorheology10:585-594, 1973.
42.
Fagehol M., Abildgaard H., Kornstad L.Antithrombin-III concentration and ABO blood groups. Lancet1:664-665, 1971.
43.
Preston AE, Barr A.: The plasma concentration of factor VIII in the normal population. II. The effect of age, sex and blood group. Br J Haem10:238-245, 1964.
44.
Westerholm B. , Weichel B., Eklund G.: Oral contraceptive, venous thromboembolic disease and ABO types. The Lancet1:664-664, 1971.
45.
Jinck H., Westerholm B., Vessey MP, et al: Venous thromboembolic disease and ABO blood type. The Lancet1:539-542, 1969.
46.
Joysey VC, Roger JH, Evans DB, et al: Differential kidney graft survival associated with interaction between recipient ABO group and pretransplant transfusion. Transplantation24:371-376, 1977.
47.
Opelz G., Terasaki PL: Effect of blood group on relation between HLA match and outcome of cadaver kidney transplant. Lancet1:220-222, 1977.
48.
Horwich L., Evans Dap, McConnell RB, et al: ABO blood groups in gastric bleeding. Gut7:680-685, 1966.
49.
Aird I., Bentall HH, Fraser Rja: A relationship between cancer of stomach and ABO blood groups. Br Med J1:799-802, 1953.
50.
Buckwalter JA, Wohlwend GB, Colter DC, et al: The association of the ABO blood groups to gastric carcinoma. Surg Gynecol Obstet104:176-179, 1957.
51.
Kaolan AP: Trend in microvascular research. The Hageman factor dependent pathway of human plasma. Microvasc Res; 8:97-111, 1974.
52.
Schricker KT , Hermanek P., Guggenmoos-Holzmann I., et al: Decreased survival in colorectal cancer. Surprising results of a multivariate analysis. Beitr-Infusionther26:307-312, 1990.
53.
Marsh J., Donnan PT, Hamer-Hodges DW: Association between transfusion with plasma and the recurrence of colorectal carcinoma. Br J Surg77: 623-626, 1990.
54.
Greig PD, Woolf GM, Sinclair SB, et al: Treatment of primary liver nonfunction with prostagladin E 1Transplantation48:447-453, 1989.
55.
Bryan BA, Henry ML, Ferguson RM: The effect of calcium sequestration on hyperacute rejection and xynograft survival. Surgical Forum42:388-390, 1991.
56.
Baliazin VA , Siziakian LP, Bulgakuf W., et al: The effect of autologous blood transfusion on immunity in operated on neurological patients. Zh-Vopr-Neirohkir4:23-25, 1990.
